Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures

Table 1 Demographic Data of the Teriparatide and Control Groups

Parameters	Group A	Group B	p value
Parameters	N = 52	N = 40	p value
Variables
Age at time of operation (yrs)	71.0 ± 8.3	72.1 ± 7.6	0.682
Body mass index (kg/m2)	26.9 ± 2.5	25.9 ± 3.1	0.693
ASA classification			0.829
ASA I	-	-	-
ASA II	33 (63.5 %)	24 (60.0 %)
ASA III	19 (36.5 %)	16 (40.0 %)
Hospital stay (day)	7.3 ± 1.6	6.9 ± 1.6	0.464
BMD of contralateral hip (T-score)	−4.3 ± 1.2	−4.2 ± 1.0	0.908
Femoral stem-canal ratio (%)	88.3 ± 5.2	87.6 ± 5.3	0.620
Follow-up (months)	27.1 ± 7.3	26.2 ± 7.4	0.650

Group A: patients without supplementary pharmacologic treatment
Group B: patients treated with teriparatide
Values are shown as mean (standard deviation) or as the n (%)
p-values for between-group comparisons were determined by the chi-squared test and Fisher’s exact test for categorical variables and Student’s t test for continuous variables
*Statistically significant (p < 0.05)

ISSN: 1471-2474